Literature DB >> 15105823

Use of voriconazole in candida retinitis.

D Varma, H R Thaker, P J Moss, K Wedgwood, J R Innes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15105823     DOI： 10.1038/sj.eye.6701427

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Fundoscopy screening for intraocular candida in patients with positive blood cultures-is it justified?

Authors:  Mariam El-Abiary; Brian Jones; Graeme Williams; David Lockington
Journal:  Eye (Lond)       Date:  2018-07-06       Impact factor: 3.775

2.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

3.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

4.  Pharmacokinetics and pharmacodynamics of anidulafungin for experimental Candida endophthalmitis: insights into the utility of echinocandins for treatment of a potentially sight-threatening infection.

Authors:  J L Livermore; T W Felton; J Abbott; A Sharp; J Goodwin; L Gregson; P A Warn; S J Howard; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

5.  Voriconazole in the management of nosocomial invasive fungal infections.

Authors:  Javier Pemán; Miguel Salavert; Emilia Cantón; Isidro Jarque; Eva Romá; Rafael Zaragoza; Angel Viudes; Miguel Gobernado
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.